Literature DB >> 33375464

Head and Neck Squamous Cell Carcinoma: Epigenetic Landscape.

Kamila Romanowska1,2, Agnieszka Sobecka1,2, Agnieszka A Rawłuszko-Wieczorek3, Wiktoria M Suchorska2, Wojciech Golusiński1.   

Abstract

Head and neck squamous carcinoma (HNSCC) constitutes the sixth most prevalent cancer worldwide. The molecular pathogenesis of HNSCC includes disorders in cell cycle, intercellular signaling, proliferation, squamous cell differentiation and apoptosis. In addition to the genetic mutations, changes in HNSCC are also characterized by the accumulation of epigenetic alterations such as DNA methylation, histone modifications, non-coding RNA activity and RNA methylation. In fact, some of them may promote cancer formation and progression by controlling the gene expression machinery, hence, they could be used as biomarkers in the clinical surveillance of HNSCC or as targets for therapeutic strategies. In this review, we focus on the current knowledge regarding epigenetic modifications observed in HNSCC and its predictive value for cancer development.

Entities:  

Keywords:  DNA methylation; RNA methylation; biomarkers; epigenetics; head and neck cancer; histone modification; non-coding RNA activity; squamous cell carcinoma

Year:  2020        PMID: 33375464     DOI: 10.3390/diagnostics11010034

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  7 in total

1.  The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma.

Authors:  Enhao Wang; Yang Li; Ruijie Ming; Jiahui Wei; Peiyu Du; Peng Zhou; Shimin Zong; Hongjun Xiao
Journal:  Front Cell Dev Biol       Date:  2021-11-30

2.  Chorioallantoic membrane tumor models highlight the effects of cisplatin compounds in oral carcinoma treatment.

Authors:  Patrizia Sarogni; Ana Katrina Mapanao; Alessandra Gonnelli; Maria Laura Ermini; Sabrina Marchetti; Claudia Kusmic; Fabiola Paiar; Valerio Voliani
Journal:  iScience       Date:  2022-02-24

Review 3.  High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies.

Authors:  Lavinia Ghiani; Susanna Chiocca
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

4.  MiRNome analysis identifying miR-205 and miR-449a as biomarkers of disease progression in intestinal-type sinonasal adenocarcinoma.

Authors:  Massimo Re; Marco Tomasetti; Federica Monaco; Monica Amati; Corrado Rubini; Giacomo Sollini; Arisa Bajraktari; Federico Maria Gioacchini; Lory Santarelli; Ernesto Pasquini
Journal:  Head Neck       Date:  2021-10-14       Impact factor: 3.821

5.  Hypermethylation of PRKCZ Regulated by E6 Inhibits Invasion and EMT via Cdc42 in HPV-Related Head and Neck Squamous Cell Carcinoma.

Authors:  Hao-Fan Wang; Jian Jiang; Jia-Shun Wu; Mei Zhang; Xin Pang; Li Dai; Ya-Ling Tang; Xin-Hua Liang
Journal:  Cancers (Basel)       Date:  2022-08-27       Impact factor: 6.575

Review 6.  Pathological Role of HDAC8: Cancer and Beyond.

Authors:  Ji Yoon Kim; Hayoung Cho; Jung Yoo; Go Woon Kim; Yu Hyun Jeon; Sang Wu Lee; So Hee Kwon
Journal:  Cells       Date:  2022-10-09       Impact factor: 7.666

Review 7.  The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers.

Authors:  Dawid Dorna; Jarosław Paluszczak
Journal:  Cells       Date:  2022-03-17       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.